patientsadcom

13 results found.

Top Stocks matching your search for "patients adcom"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 4, 2023

I know it is goi g to change many lives on this bo... See more

Dec, 7, 2022

This is game changer for Kidney diseases patients.

02/0602/0802/1002/1402/1602/2102/2302/2703/0103/0303/0703/10
KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Feb 2nd 2023 - Mar 10th 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 24, 2023

"This long term study reinforces the efficacy... See more

Feb, 18, 2023

I recall an earlier posting last year of the same ... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AXSM

Axsome Therapeutics Inc

-4.66%

$65.95 - $62.88

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

That indicates excitement and demand from both phy... See more

Feb, 6, 2023

This will be a winner, the patient will reap significant rewards.

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 4, 2023

I know it is goi g to change many lives on this board and as well as much needed for patients..

Dec, 7, 2022

This is game changer for Kidney diseases patients.

Dec, 6, 2022

but it does provide better life for patients without worrying too much and pill burden ..

Nov, 15, 2022

• Patients and treating physicians need and must have this product as an alternative treatment in their array.

Nov, 14, 2022

$ARDX we are going to get a lot of money and the most important, the patients are going to get a new wonderful life.

Nov, 14, 2022

Based on the totality of the results summarized in Table 43, the benefit-risk assessment for tenapanor is positive in patients with HP receiving maintenance dialysis.”

Nov, 13, 2022

I wish I could tha each one personally for helping us make a strong case and get this lifesaving medication into the hands of those that need it most: the patients.

Nov, 7, 2022

The recent survey done in partnership with with the National Kidney Foundation which showed that 90% of patients want more treatment options was absolutely brilliant and the timing was perfection.

Nov, 6, 2022

As a company committed to putting patients first, and as a CKD patient myself, we are proud of this collaborative effort that truly captures the voice of patients with kidney disease on dialysis."

KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Feb 2nd 2023 - Mar 10th 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 24, 2023

"This long term study reinforces the efficacy and safety of AZSTARYS as an important treatment option for healthcare professionals to consider when choosing the optimal ADHD therapy for their patients."

Feb, 18, 2023

I recall an earlier posting last year of the same clinic who said patients were doing well and parents were liking the appetite benefits

Jan, 23, 2023

$KMPH On the Facebook adhd forums, a mom said her sons doctor has had a few patients on azstarys and has had no complaints.

Jan, 20, 2023

$KMPH 700 new patients last week I'll take that!

Jan, 20, 2023

but again given the seasonality of ADHD in early school season combined with the Holidays, imo pretty OK. Actually gained more net new patients then Qelbree. .

Jan, 3, 2023

However, what I like best is that it is working on actual patients.

Dec, 30, 2022

Shows a strong base of patients.

Dec, 25, 2022

Here's to a great 2023 with scripts continuing increasing by 500 plus patients per week, great IH results and submitting to the fda our arimiclomol application

Dec, 19, 2022

And they are sooo patient

Dec, 19, 2022

So I am very positive this is a good treatment for me.

AXSM

Axsome Therapeutics Inc

-4.66%

$65.95 - $62.88

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

That indicates excitement and demand from both physicians and patients on the efficacy.

Feb, 6, 2023

This will be a winner, the patient will reap significant rewards.

Jan, 13, 2023

I have treatment resistant depression and this is the first drug that has had an immediate mood-elevating effect on day 1 within 30 minutes of taking it.

Dec, 7, 2022

$AXSM Axsome Therapeutics announces that treatment with AUVELITY resulted in rapid, substantial, and durable improvements in cognitive and physical functioning in the EVOLVE open-label trial in major depressive disorder.

Nov, 28, 2022

$AXSM as an RN who works with agitated dementia patients on a daily basis, this is HUGE!

Nov, 28, 2022

Caregiver distress and burden, patient quality of life, and depressive symptoms were all statistically significantly improved compared to baseline after patients were treated with open-label AXS-05.